Biotech · Private company · San Francisco, CA, US
Utter Therapeutics Inc.
Track this companyFree. Adds Utter Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Phase I Therapeutic Award - Developing Split, Conditionally Active Peptidomimetics of IL-12 For the Treatment of Rare Pediatric DIPGFiscal year 2024 · $299.5KNIH RePORTER 75N91024C00004-0-9999-1 · fetched Nov 12, 2026